Effects of Dynorphin on the Pha-Induced Lymphocyte Proliferation in Vitro
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 9 (4) , 467-475
- https://doi.org/10.3109/08923978709035226
Abstract
The effect of the opioid peptide dynorphin (DYN) on PHA-induced lymphocyte proliferation has been evaluated in the present study. A significant increase in PHA-induced lymphocyte activation was observed when DYN was added to cultures 48 hr after the mitogenic stimulation. This effect occurred at suboptimal (3.12 and 6.25 ug/ml) PHA concentrations and at DYN doses ranging from 10-9 to 10-12 M. Conversely, DYN did not affect the lymphocyte blastogenic process either when added before, or simultaneously or after intense PHA (12.5 ug/ml) stimulation. Naloxone preincubation did not modify the above described effects. Results suggest that DYN might play a role in neuroendocrine regulation of the lymphocyte blastogenic process.This publication has 14 references indexed in Scilit:
- Immunomodulating peptidesCellular and Molecular Life Sciences, 1986
- Influence of β-endorphin on phytohemagglutinin-induced lymphocyte proliferation and on the expression of mononuclear cell surface antigens in vitroImmunopharmacology, 1985
- Biosynthesis and distribution of opioid peptidesJournal of Endocrinological Investigation, 1983
- Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content.The Journal of Experimental Medicine, 1983
- Enkephalins as immunomodulatorsInternational Journal of Immunopharmacology, 1983
- B-endorphin modulates human immune activity via non-opiate receptor mechanismsLife Sciences, 1982
- beta-Endorphin enhances lymphocyte proliferative responses.Proceedings of the National Academy of Sciences, 1982
- Dynorphin-(1-13), an extraordinarily potent opioid peptide.Proceedings of the National Academy of Sciences, 1979
- Specific Nonopiate Receptors for β-EndorphinScience, 1979
- The use of bacitracin as an inhibitor of the degradation of thyrotropin releasing factor and luteinizing hormone releasing factorBiochemical and Biophysical Research Communications, 1976